RT @immunization: #IAS2017 mtg on hep co-infection was last week in Paris. Read debate of 2016 mtg on #HMAP. What's changed in a year? http…
RT @GHWindow: Highlights from 3rd international #HIV/viral #hepatitis Co-infection meeting https://t.co/3hEychx2mw #WorldHepatitisDay #HMAP…
#IAS2017 mtg on hep co-infection was last week in Paris. Read debate of 2016 mtg on #HMAP. What's changed in a year? https://t.co/mKjNHD3a9w
Highlights from 3rd international #HIV/viral #hepatitis Co-infection meeting https://t.co/FNu1rD1mse #WorldHepatitisDay #HMAP https://t.co/8F2DEU31sM
Highlights from 3rd international #HIV/viral #hepatitis Co-infection meeting https://t.co/3hEychx2mw #WorldHepatitisDay #HMAP https://t.co/6R1nQYk44X
#HIV /viral #hepatitis: improving diagnosis, antiviral therapy and access https://t.co/FNu1rD1mse #HCV #HBV
Highlights from the 3rd international HIV/viral hepatitis Co-infection meeting - HIV/viral hepatitis: improving… https://t.co/F56ZwoSnTU https://t.co/5P4TLCHEOi
RT @iasociety: Review the highlights and outcomes from last year’s @iasociety meeting on HIV/hepatitis co-infection https://t.co/yhOeGZxnqi
Review the highlights and outcomes from last year’s @iasociety meeting on HIV/hepatitis co-infection https://t.co/yhOeGZxnqi
RT @immunization: {New in the #HMAP journal} #HIV/viral #hepatitis: improving diagnosis, therapies & access #NOhep #ILC2017 #EndAIDS https:…
RT @immunization: {New in the #HMAP journal} #HIV/viral #hepatitis: improving diagnosis, therapies & access #NOhep #ILC2017 #EndAIDS https:…
{New in the #HMAP journal} #HIV/viral #hepatitis: improving diagnosis, therapies & access #NOhep #ILC2017 #EndAIDS https://t.co/mKjNHD3a9w
#HIV/viral #hepatitis: improving diagnosis, antiviral therapy and access https://t.co/FNu1rD1mse
Highlights from the 3rd international HIV/viral hepatitis Co-infection meeting - HIV/viral hepatitis: improving… https://t.co/u4a8gTsGLk https://t.co/Jmj2Va5m4u